EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics

Joyce O'Shaughnessy, William Gradishar, Ruth O'Regan, Vijayakrishna Gadi

Clinical Breast Cancer · 2023-06 · 23 (4) · 350-362

DOI: 10.1016/j.clbc.2023.03.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Breast Cancer, 2023-06. Verfasst von Joyce O'Shaughnessy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Baylor University Medical Center, Dallas, TX; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX. Electronic address: Joyce.OShaughne…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Puma Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleNeoplasm Recurrence, LocalErb-b2 Receptor Tyrosine KinasesRisk FactorsNeoadjuvant Therapy

Stichwörter der Autor:innen

BiomarkersEarly-stage breast cancer recurrenceHER2-positive breast cancerPatient characteristicsRecurrence risk factors

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Baylor University Medical Center, Dallas, TX; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX. Electronic address: Joyce.OShaughnessy@usoncology.com.
  • Department of Medicine, Northwestern University, Chicago, IL.
  • Department of Medicine, University of Rochester, Rochester, NY.
  • Department of Medicine, University of Illinois Chicago, Chicago, IL; Translational Oncology Program, University of Illinois Cancer Center, Chicago, IL.

Förderung

  • Puma Biotechnology

Zitieren

APA

O'Shaughnessy, J., Gradishar, W., O'Regan, R., & Gadi, V. (2023). Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics. Clinical Breast Cancer, 23(4), 350-362. https://doi.org/10.1016/j.clbc.2023.03.007

Vancouver

O'Shaughnessy J, Gradishar W, O'Regan R, Gadi V. Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics. Clinical Breast Cancer. 2023;23(4):350-362. doi:10.1016/j.clbc.2023.03.007

BibTeX
@article{OShaughnessy2023,
  author = {O'Shaughnessy, Joyce and Gradishar, William and O'Regan, Ruth and Gadi, Vijayakrishna},
  title = {Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics},
  journal = {Clinical Breast Cancer},
  year = {2023},
  volume = {23},
  number = {4},
  pages = {350--362},
  doi = {10.1016/j.clbc.2023.03.007}
}
Kostenlos starten →